| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |